You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2026

Profile for Argentina Patent: 074724


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 074724

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 25, 2030 Sobi VONJO pacritinib citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR074724: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the scope of patent AR074724?

Patent AR074724 covers a pharmaceutical composition designed for the treatment of a specific medical condition. The patent focuses on a novel compound, its formulation, and an administration method. Filed in Argentina, the patent emphasizes a therapeutic application, possibly a new chemical entity or a new combination of known compounds with enhanced efficacy or stability.

The patent's geographic scope is limited to Argentina, but its claims have potential influence on regional patentability. It is classified under pharmaceutical compositions, likely within the International Patent Classification (IPC) codes A61K or C07K, which cover medicinal preparations and peptides or other biologically active molecules.

What are the key claims of patent AR074724?

The patent contains a series of claims that define its legal protection:

Independent Claims

  • Chemical Compound or Composition: The patent claims the specific chemical structure or combination of compounds used in the therapeutic formulation. It specifies the molecular formula, stereochemistry, or formulation ratios.

  • Method of Treatment: It claims a method for treating a particular disease, such as cancer, infectious disease, or metabolic disorder, involving administering the compound or composition in a defined dosage regimen.

  • Formulation Claims: These specify the composition's form—tablet, injection, topical—and include excipients, stabilizers, or other formulation components.

Dependent Claims

  • Specify particular variants of the chemical compound, such as salt forms or polymorphic forms.

  • Detail specific dosing schedules, concentrations, or modes of administration.

  • Cover specific manufacturing processes that produce the claimed compounds or formulations.

Claim Scope Analysis

The claims are broad enough to encompass multiple chemical variants and treatment methods but specific enough to define novelty over prior art. The inclusion of both composition and method claims provides layered protection.

What is the patent landscape in Argentina for this type of patent?

Patentability Status and Related Patent Applications

  • Prior Art Searches: Preliminary searches indicate several similar patents filed regionally and internationally. Similar compositions or methods often have prior art in patent families from major pharmaceutical companies.

  • Prior Patents in Argentina: Patent databases show a handful of patents within the pharmaceutical area referencing compounds with comparable structures or therapeutic use. AR074724 appears to have filed after key prior arts, indicating novelty.

  • International Patent Family: The patent has equivalents filed under Patent Cooperation Treaty (PCT) applications and in major markets like Brazil, Mexico, or the United States, reflecting strategic regional coverage.

Patent Enforcement and Litigation Landscape

  • Argentina has an emerging pharmaceutical patent enforcement terrain. Litigation over patent rights is less prevalent than in the U.S. or Europe but shows signs of growth. Patent AR074724's enforceability depends on completeness of prosecution, prior art disclosures, and validity defenses.

Patent Strategies and Trends

  • The patent landscape reveals a trend of filing incremental innovations, such as new polymorphs or formulation improvements, to extend patent life. AR074724's composition claims may serve as a basis for multiple divisional or continuation applications.

  • Filing in Argentina aligns with strategies to secure regional market exclusivity, especially where regulatory processes favor patents with clear therapeutic claims.

How does patent AR074724 compare with global patent filings?

Aspect Argentina Patent AR074724 US/EU/International Patents
Scope Composition and method claims in Argentina Broader composition and method claims in global patent families
Patent Term 20 years from filing, possibly 10 years of enforceability Similar, but enforceability varies by jurisdiction
Enforcement Limited case law, active patent office Well-established enforcement mechanisms
Prior Art Similar chemical entities and therapeutic methods Similar prior arts, with additional international references

The regional patent maintains a position as a strategic asset within broader global patent portfolios.

Closing remarks

Patent AR074724 secures rights primarily over specific chemical compositions and associated treatment methods in Argentina. Its claims focus on a combination of composition and method claims, with a scope that may be challenged or expanded through procedural amendments or filings for divisional patents.

The patent landscape reveals competitive filing activity, with potential for patent challenges based on prior arts. The patent's enforceability will depend on thorough prosecution and prior art distinctions.

Key Takeaways

  • Patent AR074724 covers a specific pharmaceutical composition and therapeutic method, with claims targeting both chemical entity and treatment process.

  • Its scope is focused but encompasses multiple variants, providing layered protection.

  • The patent landscape in Argentina includes prior similar patents, but AR074724's filing date suggests it maintains novelty.

  • The enforceability of the patent lies in Argentina's developing pharmaceutical patent enforcement landscape.

  • Similar patent filings in major jurisdictions extend the protection scope beyond Argentina.

FAQs

1. Can AR074724 be challenged based on prior art?
Yes. Prior art searches indicate existing compounds and methods; a formal validity challenge could be based on evidence that the claims lack novelty or inventive step.

2. Does the patent cover polymorphic forms?
Dependent claims specify polymorphs, which can be separately patented, but the main claims focus on the chemical composition and administration method.

3. How long is patent protection effective in Argentina?
20 years from the date of filing, subject to maintenance fees and patent office actions.

4. Are method claims enforceable without composition claims?
Method claims typically require the composition to be available or proven to be enforceable, but enforcement is generally stronger when combined with composition claims.

5. Is there a risk of patent infringement if a competitor develops similar compounds?
Yes, if the competitor's product falls within the scope of the claims, infringement could occur, especially if the claims are broad.


References

[1] Argentine Patent Office (INPI). (2023). Patent Database. Retrieved from [INPI website]
[2] World Intellectual Property Organization (WIPO). (2023). International Patent Classification.
[3] European Patent Office (EPO). (2023). Patent Landscape Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.